COVID-19 in Alzheimer's Disease and Dementia

List of contributors Preface Section One: COVID-19 1 COVID-19 and immunity: an overviewPulak R. Manna, Zachery C. Gray, and P. Hemachandra Reddy 1 Introduction 2 COVID-19: risk factors and pathogenesis 3 COVID-19 variants and their impact on global health tragedy 4 Nutrients and immune health, and their relevance to COVID-19 5 Immunocompromised conditions and COVID-19 6 Diverse measures for preventing COVID-19 7 Potential therapies for the treatment of COVID-19 8 Summary and conclusions Acknowledgments References 2 Role of oxidative stress in the severity of SARS-COV-2 infection Sharda P. Singh, Sanjay Awasthi, Ashly Hindle, and Chhanda Bose 1 Oxidative stress and lipid peroxidation 2 Inflammatory stress3 Quenching lipid peroxidation 4 4-HNE in COVID-19 5 Functions of 4-HNE with possible relevance to COVID-19 References 3 Immune enhancers for COVID-19 Katherine G. Holder, Bernardo Galvan, Pulak R. Manna, Zachery C. Gray, and P. Hemachandra Reddy 1 Introduction 2 Immune enhancementdsupplements 3 Immune enhancersddiet, herbs, and spices 4 Conclusion References 4 Diabetes mellitus in relation to COVID-19 Bhagavathi Ramasubramanian, Jonathan Kopel, Madison Hanson, and Cameron Griffith 1 Introduction 2 Type 1 diabetes and type 2 diabetes 3 Biomarkers and risk factors in COVID-19-infected patients 4 Entry of SARS-CoV-2 into the host 5 Complications of diabetes during COVID-19 infection 6 Treatment and management of diabetes during COVID-19 infection 7 The effect of lockdowns on diabetes and obesity 8 Lifestyle and diet during COVID-19 pandemic 9 Conclusion References 5 Food bioactive compounds, sources, and their effectiveness during COVID-19 Giridhar Goudar, Munikumar Manne, Jangampalli Adi Pradeepkiran, and Subodh Kumar 1 Introduction 2 COVID-19 and food safety 3 Bioactive compounds 4 Foods containing bioactive compounds helpful during COVID-19 infection 5 Mechanistic activity of bioactive compounds helpful for COVID-19 6 Conclusion References 6 MicroRNAs and COVID-19 Prashanth Gowda, Vivek Kumar, Ashish Sarangi, Jangampalli Adi Pradeepkiran, P. Hemachandra Reddy, and Subodh Kumar 1 Introduction 2 MicroRNAs as biomarkers for COVID-19 3 Molecular basis of microRNAs in COVID-19 infection 4 MicroRNAs as therapeutic for COVID-19 5 Conclusion References 7 Mechanisms and implications of COVID-19 transport into neural tissue Katherine G. Holder, Bernardo Galvan, and Alec Giakas 1 Introduction 2 Viruses and neurological damage 3 SARS-CoV-2 virulence and neurologic invasion 4 Conclusion References Further reading 8 Immunogenetic landscape of COVID-19 infections related neurological complicationsBalakrishnan Karuppiah, Rathika Chinniah, Sasiharan Pandi, Vandit Sevak, Padma Malini Ravi, and Dhinakaran Thadakanathan 1 Introduction 2 HLA immunogenetic variations 3 HLA immunogenetics and COVID-19 4 HLA associations in COVID-19 induced neurological disorders 5 Conclusions References 9 Impact of COVID-19 on ischemic stroke condition Tochi Eboh, Hallie Morton, P.